Andreas Smyris
About Andreas Smyris
Andreas Smyris is a Cell Therapy Specialist at Kite Pharma and a Co-Founder and Board member at Authentia Foundation. He holds a Bachelor's degree in Materials Science and Engineering from the University of Ioannina and a Master's degree in Chemical Engineering from the University of Twente.
Work at Kite Pharma
Andreas Smyris has been employed at Kite Pharma as a Cell Therapy Specialist since 2021. He works in the Amsterdam Area, contributing to the development and implementation of innovative cell therapy solutions. His role involves leveraging his expertise in materials science and chemical engineering to enhance therapeutic approaches in the field of cell therapy.
Education and Expertise
Andreas Smyris holds a Bachelor's degree in Materials Science and Engineering from the University of Ioannina, which he completed from 2010 to 2016. He furthered his education by obtaining a Master's degree in Chemical Engineering from the University of Twente between 2017 and 2019. His academic background provides a strong foundation for his work in health sciences, particularly in biomedical applications.
Background
Before his current roles, Andreas Smyris gained valuable experience as a Materials Engineer - Researcher at the University of Ioannina from 2014 to 2016. He also completed a graduation project at the University of Twente from 2019 to 2020. His internships at Geotest S.A. in 2014 and Tide Microfluidics B.V. in 2018 further enriched his practical knowledge in the field.
Achievements
Andreas Smyris co-founded the Authentia Foundation in 2020, where he serves as a Board member. His involvement in this organization reflects his commitment to advancing biomedical engineering and innovation. Additionally, he held a position as a Board Member at IAESTE from 2018 to 2019, contributing to the promotion of international internships in engineering and technology.
Research Interests
Andreas Smyris has a strong interest in advancing biomedical engineering, focusing on areas such as bio-materials, drug delivery systems, and artificial organs. His research experience in materials science and engineering informs his current work in cell therapy, allowing him to explore innovative solutions within health sciences.